Amyotrophic lateral sclerosis is a degenerative disorder of motor neurons that typically develops in the 6th decade and is uniformly fatal, usually within 5 years. To identify genetic variants associated with susceptibility and phenotypes in sporadic ALS, we performed a genome-wide SNP analysis in sporadic ALS cases and controls. A total of 288,357 SNPs were screened in a set of 1,821 sporadic ALS cases and 2,258 controls from the U. S. and Europe. Survival analysis was performed using 1,014 deceased sporadic cases. Top results for susceptibility were further screened in an independent sample set of 538 ALS cases and 556 controls. SNP rs1541160 within the KIFAP3 gene (encoding a kinesin-associated protein) yielded a genome-wide significant result ( P = 1.84 x 10(-8)) that withstood Bonferroni correction for association with survival. Homozygosity for the favorable allele (CC) conferred a 14.0 months survival advantage. Sequence, genotypic and functional analyses revealed that there is linkage disequilibrium between rs1541160 and SNP rs522444 within the KIFAP3 promoter and that the favorable alleles of rs1541160 and rs522444 correlate with reduced KIFAP3 expression. No SNPs were associated with risk of sporadic ALS, site of onset, or age of onset. We have identified a variant within the KIFAP3 gene that is associated with decreased KIFAP3 expression and increased survival in sporadic ALS. These findings support the view that genetic factors modify phenotypes in this disease and that cellular motor proteins are determinants of motor neuron viability.

Reduced expression of the kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic Amyotrophic Lateral Sclerosis / J.E. Landers, J. Melki, V. Meninger, J.D. Glass, L.H. van den Berg, M.A. van Es, P.C. Sapp, P.W. van Vught, D.M. McKenna Yasek, H.M. Blauw, T.J. Cho, M. Polak, L. Shi, A.M. Wills, W. Broom, N. Ticozzi, V. Silani, A. Ozoguz, I. Rodriguez Leyva, J.H. Veldink, A.J. Ivinson, C.G. Saris, B.A. Hosler, A. Barnes Nessa, N. Couture, J.H. Wokke, T. J. Kwiakowski J. r., R.A. Ophoff, S. Cronin, O. Hardiman, F.P. Diekstra, P.N. Leigh, C.E. Shaw, C.L. Simpson, V.K. Hansen, J.F. Powell, P. Corcia, F. Salachas, S. Health, P. Galan, F. Geoges, H.R. Horvitz, M. Lathrop, S. Purcell, A. Al Chalabi, R.H. Brown. - In: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. - ISSN 0027-8424. - 106:22(2009), pp. 9004-9009. [10.1073/pnas.0812937106]

Reduced expression of the kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic Amyotrophic Lateral Sclerosis

N. Ticozzi;V. Silani;
2009

Abstract

Amyotrophic lateral sclerosis is a degenerative disorder of motor neurons that typically develops in the 6th decade and is uniformly fatal, usually within 5 years. To identify genetic variants associated with susceptibility and phenotypes in sporadic ALS, we performed a genome-wide SNP analysis in sporadic ALS cases and controls. A total of 288,357 SNPs were screened in a set of 1,821 sporadic ALS cases and 2,258 controls from the U. S. and Europe. Survival analysis was performed using 1,014 deceased sporadic cases. Top results for susceptibility were further screened in an independent sample set of 538 ALS cases and 556 controls. SNP rs1541160 within the KIFAP3 gene (encoding a kinesin-associated protein) yielded a genome-wide significant result ( P = 1.84 x 10(-8)) that withstood Bonferroni correction for association with survival. Homozygosity for the favorable allele (CC) conferred a 14.0 months survival advantage. Sequence, genotypic and functional analyses revealed that there is linkage disequilibrium between rs1541160 and SNP rs522444 within the KIFAP3 promoter and that the favorable alleles of rs1541160 and rs522444 correlate with reduced KIFAP3 expression. No SNPs were associated with risk of sporadic ALS, site of onset, or age of onset. We have identified a variant within the KIFAP3 gene that is associated with decreased KIFAP3 expression and increased survival in sporadic ALS. These findings support the view that genetic factors modify phenotypes in this disease and that cellular motor proteins are determinants of motor neuron viability.
genome-wide association study; single nucleotide polymorphism
Settore MED/26 - Neurologia
2009
Article (author)
File in questo prodotto:
File Dimensione Formato  
Landers JE PNAS 2009.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 648.33 kB
Formato Adobe PDF
648.33 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/71011
Citazioni
  • ???jsp.display-item.citation.pmc??? 71
  • Scopus 158
  • ???jsp.display-item.citation.isi??? 149
social impact